Beginning in
Phase I/II…

Significant experience in new product development and marketing. This defines and distinguishes The Exeter Group. 

The Exeter Group convenes expert panels to help define clinical development plans and assess in-licensing candidates. 

We develop comprehensive publication plans to ensure that appropriate data are communicated to appropriate audiences at appropriate times.

…continuing through Phase III…

The Exeter Group designs integrated pre-marketing plans that coordinate all activities initiated prior to launch.

Editorial programs are built around the clinical development program, and are designed to ensure that your scientific message gets maximum exposure.

The quality of our relationships with leading authorities is unsurpassed, and we are ideally positioned to establish advisory boards and organize consultants' meetings that will help you successfully navigate competitive shoals.

Speaker bureaus and CME-accredited symposia will help educate important audiences.

…through approval and launch

It is crucial to speak to physicians and other healthcare professionals in the language they understand. The Exeter Group develops a full range of medical education programs that efficiently and effectively target varied medical audiences and withstand regulatory scrutiny.

Because we understand your product’s positioning, we can, when required, design these programs independently, without your direct involvement. We let you focus on other things.

Closed symposia, home-study courses, direct mail, and audiovisual programs are all part of the medical education mix.